Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ALC Alcon Inc. | ABBV AbbVie |
|---|---|---|
| Price | $66.75 +1.1% | $261.81 +1.8% |
| StockIQ Score | 29F Weak Risk: High | 54C- Moderate Risk: Medium |
| Technical | 10F | 61C+ |
| Fundamental | — | 56C |
| Growth | — | 34F |
| Fair Value | — | 33F |
| News | 68B- | 100A+ |
| Quality | — | 47D+ |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Alcon Inc. (ALC) has a lower overall investor score (42) and a weaker rating (WEAK) compared to AbbVie (ABBV), which scores 52 with a MODERATE rating. AbbVie also leads in technical (58 vs. 36) and fundamental (56 vs. unavailable) scores, showing stronger investor confidence and stability. The only advantage ALC has is its higher growth score, though that data isn’t provided for AbbVie.